Ligand · XZM
XZM · N-(1,3-benzothiazol-2-yl)-2-(4-{[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl) sulfonyl]carbamoyl}-1,3-thiazol-2-yl)-1,2,3,4-tetrahydroisoquinoline-8-carboxamide
XZM, N-(1,3-benzothiazol-2-yl)-2-(4-{[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl) sulfonyl]carbamoyl}-1,3-thiazol-2-yl)-1,2,3,4-tetrahydroisoquinoline-8-carboxamide (C42 H40 F3 N7…
- Component
- XZM
- Formula
- C42 H40 F3 N7 O7 S5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
XZM in 1 structure; the first of them:
- 7LH7 · Crystal structure of BCL-xl in complex with a benzothiazole-based inhibitor · XZM A4000 · binds ALA93, GLU96, PHE97, TYR101, ARG102, PHE105, SER106, ASP107 and 19 more
Residues it binds most
ALA 2, PHE 2, ASN 2, LEU 2, ARG 2, GLU 2, SER 2, TYR 2, ASP 2, GLY 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.